Ekkehard Schütz
Chief Tech/Sci/R&D Officer at ONCOCYTE CORPORATION
Profile
Dr. Ekkehard Schütz is a Chief Science Officer at OncoCyte Corp.
and a Chief Executive Officer & Chief Medical Officer at Chronix Biomedical, Inc. He received his doctorate degree from the University of Gottingen.
Ekkehard Schütz active positions
| Companies | Position | Start |
|---|---|---|
| ONCOCYTE CORPORATION | Chief Tech/Sci/R&D Officer | 2021-03-31 |
Chronix Biomedical, Inc.
 Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Chief Executive Officer | - |
Training of Ekkehard Schütz
| University of Gottingen | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| ONCOCYTE CORPORATION | Health Technology |
| Private companies | 1 |
|---|---|
Chronix Biomedical, Inc.
Chronix Biomedical, Inc. Medical SpecialtiesHealth Technology Chronix Biomedical, Inc. manufactures diagnostic substances chemicals. It develops DNA-based blood tests primarily for monitoring minimal residual disease in cancer patients. The firm also develops a technology that measures personalized biomarkers in cancers of the colorectum, prostate, lung, ovarian, pancreas, blood and central nervous system. The company was founded by Wiiliam A. Boeger and Howard B. Urnovitz in 1997 and is headquartered in San Jose, CA. | Health Technology |
- Stock Market
- Insiders
- Ekkehard Schütz
